Cui et al. described a triad of markers (anti-cofillin-1, anti-alpha-enolase, and anti-Rho GDP-dissociation inhibitor 2) overexpressed in patients with SS who developed MALT lymphoma compared with SS patients and healthy individuals [125]. This evidence concerns the gene ARHGDIB and synovial sarcoma.